January 22, 2013
On January 22, 2013, the United States Court of Appeals for the District of Columbia Circuit issued a ruling supporting the federal Drug Enforcement Administration's (DEA) classification of marijuana as a dangerous drug with no accepted medical uses supported by large late-stage clinical trials. The ruling was on an appeal filed in January 2012 by Americans for Safe Access (ASA), a national medical marijuana advocacy organization, on a lower court ruling in July 2011 denying a 2002 petition asking the DEA to reclassify marijuana from a Schedule I substance to a Schedule II substance under . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.